enVVeno Medical Participates in the Virtual Investor "What鈥檚 Your Story" Summer Spotlight On-Demand Conference
enVVeno Medical (NASDAQ:NVNO), a company focused on deep venous disease treatment, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference. CEO Rob Berman presented at the conference, sharing insights about his leadership journey and his passion for the company's products under development.
The presentation is now accessible on-demand through virtualinvestorco.com and the Events section of enVVeno's website.
enVVeno Medical (NASDAQ:NVNO), un'azienda specializzata nel trattamento delle malattie venose profonde, ha annunciato la sua partecipazione alla conferenza virtuale on-demand "What's Your Story" Summer Spotlight organizzata da Virtual Investor. Il CEO Rob Berman ha tenuto una presentazione durante l'evento, condividendo la sua esperienza di leadership e la passione per i prodotti in sviluppo dell'azienda.
La presentazione 猫 ora disponibile on-demand su virtualinvestorco.com e nella sezione Eventi del sito web di enVVeno.
enVVeno Medical (NASDAQ:NVNO), una empresa enfocada en el tratamiento de enfermedades venosas profundas, anunci贸 su participaci贸n en la conferencia virtual bajo demanda "What's Your Story" Summer Spotlight organizada por Virtual Investor. El CEO Rob Berman present贸 en la conferencia, compartiendo sus experiencias de liderazgo y su pasi贸n por los productos en desarrollo de la compa帽铆a.
La presentaci贸n est谩 ahora disponible on-demand en virtualinvestorco.com y en la secci贸n de Eventos del sitio web de enVVeno.
enVVeno Medical (NASDAQ:NVNO)電� 鞁秬鞝曤Д 歆堩櫂 旃橂鞐� 欷戩爯鞚� 霊� 須岇偓搿�, Virtual Investor臧� 欤检禍頃橂姅 臧�靸� 韴瀽鞛� 'What's Your Story' 鞐 鞀ろ彫韸鸽澕鞚错姼 鞓敂毵摐 旎嵓霟办姢鞐� 彀胳棳頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. CEO Rob Berman鞚� 旎嵓霟办姢鞐愳劀 毽崝鞁� 鞐爼瓿� 須岇偓 臧滊皽 鞝滍拡鞐� 雽�頃� 鞐挫爼鞚� 瓿奠湢頄堨姷雼堧嫟.
氚滍憸 鞓侅儊鞚� 順勳灛 virtualinvestorco.com瓿� enVVeno 鞗轨偓鞚错姼鞚� 鞚措菠韸� 靹轨厴鞐愳劀 鞓敂毵摐搿� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
enVVeno Medical (NASDAQ:NVNO), une entreprise sp茅cialis茅e dans le traitement des maladies veineuses profondes, a annonc茅 sa participation 脿 la conf茅rence virtuelle 脿 la demande "What's Your Story" Summer Spotlight organis茅e par Virtual Investor. Le PDG Rob Berman a pr茅sent茅 lors de la conf茅rence, partageant son parcours de leadership et sa passion pour les produits en cours de d茅veloppement par la soci茅t茅.
La pr茅sentation est d茅sormais accessible 脿 la demande sur virtualinvestorco.com ainsi que dans la section 脡v茅nements du site web d'enVVeno.
enVVeno Medical (NASDAQ:NVNO), ein Unternehmen, das sich auf die Behandlung von tiefen Venenerkrankungen spezialisiert hat, gab seine Teilnahme an der virtuellen Investorenkonferenz "What's Your Story" Summer Spotlight On-Demand bekannt. CEO Rob Berman pr盲sentierte auf der Konferenz und teilte Einblicke in seine F眉hrungserfahrung sowie seine Leidenschaft f眉r die in Entwicklung befindlichen Produkte des Unternehmens.
Die Pr盲sentation ist nun on-demand 眉ber virtualinvestorco.com und im Veranstaltungsbereich der enVVeno-Website verf眉gbar.
- None.
- None.
- Video webcast now available on-demand
IRVINE, CA / / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that , participated in the .
As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's products in development.
The on-demand video webcast is now available on as well as the page of the enVVeno website, .
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve庐, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe庐. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
FAQ
When did enVVeno Medical (NVNO) participate in the Virtual Investor Summer Spotlight Conference?
Where can investors watch the enVVeno Medical (NVNO) Virtual Investor Conference presentation?
What did enVVeno Medical's CEO discuss in the Virtual Investor Conference?
What is enVVeno Medical's (NVNO) main business focus?
